Seoulin Financial Statements From 2010 to 2025
| 038070 Stock | KRW 7,340 230.00 3.23% |
Check Seoulin Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Seoulin Bioscience's main balance sheet or income statement drivers, such as , as well as many indicators such as . Seoulin financial statements analysis is a perfect complement when working with Seoulin Bioscience Valuation or Volatility modules.
Seoulin |
Seoulin Bioscience CoLtd Company Current Valuation Analysis
Seoulin Bioscience's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Seoulin Bioscience Current Valuation | 165.44 B |
Most of Seoulin Bioscience's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Seoulin Bioscience CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Seoulin Bioscience CoLtd has a Current Valuation of 165.44 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
Seoulin Bioscience CoLtd Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Seoulin Bioscience's current stock value. Our valuation model uses many indicators to compare Seoulin Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seoulin Bioscience competition to find correlations between indicators driving Seoulin Bioscience's intrinsic value. More Info.Seoulin Bioscience CoLtd is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.01 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Seoulin Bioscience CoLtd is roughly 195.19 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Seoulin Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Seoulin Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Seoulin Bioscience Financial Statements
Seoulin Bioscience stakeholders use historical fundamental indicators, such as Seoulin Bioscience's revenue or net income, to determine how well the company is positioned to perform in the future. Although Seoulin Bioscience investors may analyze each financial statement separately, they are all interrelated. For example, changes in Seoulin Bioscience's assets and liabilities are reflected in the revenues and expenses on Seoulin Bioscience's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Seoulin Bioscience CoLtd. Please read more on our technical analysis and fundamental analysis pages.
,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company was founded in 1984 and is headquartered in Seongnam, South Korea. SeouLin is traded on Korean Securities Dealers Automated Quotations in South Korea.
Pair Trading with Seoulin Bioscience
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Seoulin Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seoulin Bioscience will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Seoulin Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Seoulin Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Seoulin Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Seoulin Bioscience CoLtd to buy it.
The correlation of Seoulin Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Seoulin Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Seoulin Bioscience CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Seoulin Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Seoulin Stock
Seoulin Bioscience financial ratios help investors to determine whether Seoulin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seoulin with respect to the benefits of owning Seoulin Bioscience security.